Citigroup’s Bicara Therapeutics Inc. Common Stock BCAX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$107K	Sell	11,520 -5,938	-34%	-$55.2K	﹤0.01%	3648
2025 Q1	$227K	Buy	17,458 +1,970	+13%	+$25.7K	﹤0.01%	3370
2024 Q4	$270K	Buy	15,488 +15,236	+6,046%	+$265K	﹤0.01%	3400
2024 Q3	$6.42K	Buy	+252	New	+$6.42K	﹤0.01%	4534